Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
A randomized, double-blind, placebo-controlled phase Ib treatment trial to evaluate Fecal Microbiota Transplantation (FMT) or placebo in 25 randomized patients (aged 4 to 17 years) with active Ulcerative Colitis (UC) (1)
Pediatric UC activity index, C-reactive protein, or fecal calprotectin (1)
92% of the children who received Fecal Microbiota Transplantation (FMT) showed improvement in their condition, compared to 50% of those who received a placebo after 6 weeks. This means that the treatment was 1.8 times more effective, …